| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.03 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |